Portugal and Other Countries Submit Objections in Brussels Over UK Smoke-Free Generation Bill

Apr.24
Portugal and Other Countries Submit Objections in Brussels Over UK Smoke-Free Generation Bill
Portugal is among the countries opposing the UK Tobacco and Vapes Bill, which would ban tobacco sales to people born on or after Jan. 1, 2009. According to the report, Portugal, Croatia, the Czech Republic, Greece, Italy, Slovakia and Romania have submitted reasoned opinions and formal observations to Brussels, arguing that the bill breaches post-Brexit arrangements including the Windsor Framework.

Key Takeaways

  • Portugal and six other countries have submitted objections in Brussels over the UK Tobacco and Vapes Bill.
  • The countries are Portugal, Croatia, the Czech Republic, Greece, Italy, Slovakia and Romania.
  • Portuguese sources said the bill “clearly contravenes the principles of the treaties, as well as the Windsor Framework.”
  • The objections focus on the possibility that the bill could create unjustified barriers to the free movement of goods between the UK and the European single market.
  • The UK Department of Health said the legislation is “fully compatible” with international obligations relating to Northern Ireland.

2Firsts, April 24,2026 

 

According to SIC Notícias, Portugal is one of the countries opposing the UK Tobacco and Vapes Bill. The bill would ban the sale of tobacco products to people born on or after Jan. 1, 2009.

 

Seven countries submitted objections to Brussels


The report said that, in addition to Portugal, Croatia, the Czech Republic, Greece, Italy, Slovakia and Romania have submitted “reasoned opinions” and “formal observations” to Brussels, setting out why they believe the bill is unlawful.

 

Portugal said the bill breaches the Windsor Framework


Portuguese sources told SIC Notícias that the legislation “clearly contravenes the principles of the treaties, as well as the Windsor Framework.” 

 

The Windsor Framework is the legal mechanism agreed between London and Brussels in 2023 to ease customs controls involving Northern Ireland.

 

The core dispute centers on barriers to the movement of goods


SIC Notícias said the concerns raised by those countries center on possible restrictions resulting from the law. In their view, those restrictions would “create unjustified barriers to the free movement of goods at the borders between the UK and the European single market.”

 

The issue could lead to formal talks between Brussels and London


According to The Times, the dispute “could lead to formal talks between Brussels and London, and, as a last resort, to a legal dispute.”


The report also said the bill has been backed in the UK House of Commons and is due to be debated in the House of Lords.


The UK Department of Health told The Times that the legislation is “fully compatible with international obligations in relation to Northern Ireland.”

 

UK officials said the bill will save lives


Baroness Gillian Merron, parliamentary undersecretary of state at the Department of Health and Social Care, told the Lords on Monday that the measure is “the biggest public health intervention in a generation” and said it “will save lives.”

 

 Image source: Portugal Resident.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
Vapesourcing Lists RELX Creator Pro 15K as “Coming Soon,” Shows U.S. Warehouse Shipping Options
2Firsts found that U.S.-facing and cross-border vape retailer Vapesourcing has created a product page for the “RELX Creator Pro 15K Disposable Vape Kit 3%,” marked as “Coming Soon.” The page lists U.S. warehouse shipping options, but does not show that the product is currently available for purchase.
Market
Jun.08
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Disposable Vape Ban Shifts Purchasing Formats as UK Vape Volume Falls 10.3%
Data from convenience insight agency Talysis shows that the value of tobacco, vapes and smoking alternatives in the independent convenience sector fell by 4.4% in the first quarter of 2026, while volume fell by 7.8%. The vaping subcategory declined by 3.9% in value and 10.3% in volume over the same period. Talysis said the impact of the disposable vape ban continues to pressure turnover and footfall.
May.08 by 2FIRSTS.ai
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26